TAM
BHVN

Tiverton Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Tiverton Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$690K Hold
16,529
– – 0.02% 341
2019
Q2 		$724K Buy
16,529
+10,307
+166% +$581K 0.03% 313
2019
Q1 		$320K Hold
6,222
– – 0.01% 468
2018
Q4 		$230K Buy
+6,222
New +$224K 0.01% 295

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Tiverton Asset Management's BHVN Position: Q3 2019 in Review

Tiverton Asset Management held its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) position steady in Q3 2019 at 16,529 shares worth $690K. The position accounts for 0.02% of the portfolio, ranked #341.

Tiverton Asset Management first reported a position in BHVN in Q4 2018 and has held it in 4 quarters since. The position peaked at $724K in Q2 2019. 184 funds tracked by Wall St. Rank hold BHVN as of Q3 2019.

  • Tiverton Asset Management held 16,529 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $690K as of Q3 2019.
  • Tiverton Asset Management left its Biohaven Pharmaceutical Holding Company Ltd. share count unchanged in Q3 2019.
  • Biohaven Pharmaceutical Holding Company Ltd. made up 0.02% of Tiverton Asset Management's portfolio in Q3 2019, its #341 holding.
  • Tiverton Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2018 and has held it in 4 quarters since.
  • Tiverton Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $724K in Q2 2019.
  • 184 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.